The JAK2 V617F mutation occurs frequently in myelodysplastic/myeloproliferative diseases, but is absent in true myelodysplastic syndromes with fibrosis.
Leukemia20, 1315-1316 (2006)
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.